| Recruitment status | Main results already published |
| Unique ID issued by UMIN | UMIN000025811 |
| Receipt No. | R000029680 |
| Scientific Title | Effect of a plant derived food on energy metabolism in healthy women |
| Date of disclosure of the study information | 2017/01/24 |
| Last modified on | 2020/02/18 (Ver. 7) |
| Basic information | ||
| Public title | Effect of a plant derived food on energy metabolism in healthy women | |
| Acronym | Effect of a plant derived food on energy metabolism in healthy women | |
| Scientific Title | Effect of a plant derived food on energy metabolism in healthy women | |
| Scientific Title:Acronym | Effect of a plant derived food on energy metabolism in healthy women | |
| Region |
|
|
| Condition | |||
| Condition | Healthy adults | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To investigate effect of a plant derived food on energy metabolism in healthy women |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Medical examination regarding basal metabolic rate (supine position) and resting energy expenditure after 2 weeks intervention |
| Key secondary outcomes | respiratory quotient, fat utilization, carbohydrate utilization, analysis of blood and urine |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Control food 2 weeks consumption > wash out 2 weeks > test food 2 weeks consumption | |
| Interventions/Control_2 | Test food 2 weeks consumption > wash out 2 weeks > control food 2 weeks consumption | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | (1)Age>=45 and <65 years
(2)Subjects who have given written informed consent prior to start of study |
|||
| Key exclusion criteria | (1)Subjects who have a history or signs of a heart or cerebrovascular disease
(2)Subjects having diabetes, a liver, kidney or respiratory disease, endocrine disorder, metabolic disorder, organ disorder, gout, rheumatism, autoimmune disease, allergy disease, mental disorder, cancer, infection disease, or other diseases (3)Subjects who take an antidiabetic drug or antihyperlipidemic drug (4)Subjects having thyroid deficiency (5)Subjects who have a smoking habit (6)Heavy drinker (7)Subjects who have donated over 200 mL of blood within the last one month prior to the current study or over 400 mL of blood within the last three months prior to the study (8)Subjects who have severe anemia (Hb <=7g/dL) (9)Subjects who have been to get sick by collecting venous blood (10)Subjects who have allergic reaction to food (11)Subjects who have sensitivity to control or test food (12)Subjects who are planned to participate in other clinical study during current study (13)Subjects who are pregnant, breast-feeding or have a pregnancy intention during the test period (14)Subjects having menstrual irregularity (15)Subjects who are judged to be inappropriate for the study by the medical doctor or investigator for other reason |
|||
| Target sample size | 20 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Kao Corporation | ||||||
| Division name | Health Care Food Research Laboratories | ||||||
| Zip code | 131-8501 | ||||||
| Address | 2-1-3, Bunka, Sumida-ku, Tokyo, 131-8501, Japan | ||||||
| TEL | 03-5630-7224 | ||||||
| osaki.noriko@kao.co.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Kao Corporation | ||||||
| Division name | Health Care Food Research Laboratories | ||||||
| Zip code | 131-8501 | ||||||
| Address | 2-1-3, Bunka, Sumida-ku, Tokyo, 131-8501, Japan | ||||||
| TEL | 03-5630-7266 | ||||||
| Homepage URL | |||||||
| yanagimoto.aya@kao.co.jp | |||||||
| Sponsor | |
| Institute | Kao Corporation |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Kao Corporation |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Human Research Ethics Committee, Kao Corporation |
| Address | 2-1-3, Bunka, Sumida-ku, Tokyo, 131-8501, Japan |
| Tel | 03-5630-9220 |
| morisaki.naoko@kao.com | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 花王株式会社(東京都) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | Unpublished due to the protocol including the intellectual property rights |
| Publication of results | Published |
| Result | |||||||
| URL related to results and publications | https://rd.springer.com/article/10.1007%2Fs00394-019-01976-9 | ||||||
| Number of participants that the trial has enrolled | 14 | ||||||
| Results | Significant difference in the primary outcome between the groups |
||||||
| Results date posted |
|
||||||
| Results Delayed | |||||||
| Results Delay Reason | |||||||
| Date of the first journal publication of results | |||||||
| Baseline Characteristics | healthy women |
||||||
| Participant flow | 13 completed the trial and 10 were analyzed. |
||||||
| Adverse events | None associated with the test beverage consumption |
||||||
| Outcome measures | Medical examination regarding basal metabolic rate (supine position) and resting energy expenditure after 2 weeks intervention |
||||||
| Plan to share IPD | |||||||
| IPD sharing Plan description | |||||||
| Progress | |||||||
| Recruitment status | Main results already published | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029680 |